Adial Pharmaceuticals menu
  • Home
  • About
    • About Adial
    • Management Team
    • Board of Directors
  • Pipeline
    • Pipeline Overview
    • AD04
    • Purnovate
  • Newsroom
    • Press Releases
    • Events
    • YouTube Channel
    • Articles
  • Investors
    • Overview
    • Analyst Coverage
    • News / Events
      • Press Releases
      • Upcoming Events
      • Past Events
      • Email Alerts
    • Company Info
    • Financial Information
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
    • Stock Data
      • Detailed Quote
      • Stock Charts
      • Historical Data
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Contact
    • Contact Us
    • Terms of Use
    • Privacy Policy

Management Team

  • William B. Stilley

    Founder and Chief Executive Officer

  • Cary J. Claiborne

    Chief Operating Officer

  • Bankole A. Johnson, D.Sc., M.D.

    Founder and Chief Medical Officer

  • Joseph Truluck

    Chief Financial Officer

  • Jack Reich, Ph.D

    Head of Regulatory

  • Mark H. Peikin, J.D.

    Chief Strategy Officer

  • Alex Lugovoy

    Chief Business Officer

  • John R. Martin, J.D.

    Chief Legal Officer

  • Schuyler Vinzant

    VP Development

  • Catherine Fratila

    Controller

  • Julien Dimastromatteo, Ph.D

    VP Research

  • Robert D. Thompson, Ph.D

    VP Chemistry

adial
news
  • June 28

    Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley

    Continue Reading
  • June 27

    Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial

    Continue Reading
  • June 14

    Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence

    Continue Reading
  • May 19

    Adial Pharmaceuticals Announces Research Collaboration with the Medical College of Wisconsin to Advance Purnovate’s Adenosine Compounds as Potential Treatments for Diabetes and NASH

    Continue Reading
  • May 16

    Adial Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results

    Continue Reading
adial
twitter
Tweets by AdialPharma
adial
youtube
  • video-04

    Adial Overview 2020

    Watch Now
  • video

    Adial Overview

    Watch Now
  • About the growing AUD market and Adial's targeted potential treatment

    Watch Now
  • NBC29: UVA Researchers & Adial looking into using Purnovate in Burn Wound Care

    Watch Now
  • video

    CEO Bill Stilley talks about AD04 on CBS46 Atlanta

    Watch Now
  • Newsy Morning Rush with Bill Stilley discussing AUD & AD04

    Watch Now
Adial Pharmaceuticals
About
  • About Adial
  • Management Team
  • Board of Directors
Pipeline
  • Pipeline Overview
  • AD04
  • Purnovate
Newsroom
  • Press Releases
  • Events
  • YouTube Channel
  • Articles
Investors
  • Overview
  • Analyst Coverage
  • News/Events
  • Company Info
  • Financial Info
  • Stock Data
  • SEC Filings
  • Governance
Contact
  • Contact Us
  • Terms of Use
  • Privacy Policy
Email Alerts
©Adial Pharmaceuticals 2022